Admission Date:  [**2145-9-5**]              Discharge Date:   [**2145-9-10**]

Date of Birth:  [**2090-12-8**]             Sex:   M

Service: [**Doctor First Name 147**]

Allergies:
Patient recorded as having No Known Allergies to Drugs

Attending:[**First Name3 (LF) 695**]
Chief Complaint:
SOB, increased secretions

Major Surgical or Invasive Procedure:
none


History of Present Illness:
54yo male s/p CRT who was D/C'd on [**2145-8-26**] after treatment for a
presumed CHF exacerbation. Pt now presents with again with SOB.
Pt sent to OSH and thought to be in respiratory distres. Pt
transferred to [**Hospital1 18**] on [**2145-9-5**] for management.

Past Medical History:
HTN
DM
polycystic kidney disease
Renal [**Date Range **]
DGF

Physical Exam:
AAO times 3
RRR S1+S2
Diffuse crackles throughout both lung fields
Soft, NT/ND small wound at base of graft, 2-3cm, healing well
mild bilat LE edema


Pertinent Results:
[**2145-9-5**] 10:50AM BLOOD Glucose-143* UreaN-30* Creat-1.5* Na-134
K-3.8 Cl-95* HCO3-25 AnGap-18
[**2145-9-8**] 06:00AM BLOOD Glucose-72 UreaN-42* Creat-2.4* Na-138
K-3.9 Cl-99 HCO3-28 AnGap-15
[**2145-9-10**] 06:00AM BLOOD Glucose-108* UreaN-38* Creat-1.9* Na-135
K-3.6 Cl-98 HCO3-24 AnGap-17
[**2145-9-5**] 10:55AM URINE Blood-NEG Nitrite-NEG Protein-30
Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG

[**2145-9-5**] 10:55 am SPUTUM      Source: Induced.
   GRAM STAIN (Final [**2145-9-5**]):
      >25 PMNs and <10 epithelial cells/100X field.
      4+   (>10 per 1000X FIELD):   GRAM NEGATIVE ROD(S).
      2+   (1-5 per 1000X FIELD):   GRAM POSITIVE ROD(S).
      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI IN
PAIRS.
   RESPIRATORY CULTURE (Final [**2145-9-8**]):
      SPARSE GROWTH OROPHARYNGEAL FLORA.
      Due to mixed bacterial types ( >= 3 colony types) an
abbreviated
      workup will be performed appropriate to the isolates
recovered from
      this site.
      PSEUDOMONAS AERUGINOSA.    MODERATE GROWTH.
      GRAM NEGATIVE ROD #2.    MODERATE GROWTH.
      GRAM NEGATIVE ROD #3.    MODERATE GROWTH.
                              SENSITIVITIES: MIC expressed in
MCG/ML
                             PSEUDOMONAS AERUGINOSA
CEFEPIME--------------    16 I
CEFTAZIDIME-----------  =>64 R
CIPROFLOXACIN---------   0.5 S
GENTAMICIN------------     4 S
MEROPENEM-------------     2 S
PIPERACILLIN---------- =>128 R
PIPERACILLIN/TAZO----- =>128 R
TOBRAMYCIN------------   <=1 S

CHEST (PORTABLE AP)  [**2145-9-5**] 1:53 PM
IMPRESSION:
1. Left lower lobe pneumonia.
2. Bilateral edema with cardiomegaly.
3. No pneumothorax.

CHEST (PA & LAT)  [**2145-9-6**] 7:32 PM
IMPRESSION: Significant improvement in severity of the bilateral
pulmonary infiltrates. Persistent LV enlargement with minimal
evidence of residual cardiac failure.


Brief Hospital Course:
Pt admitted on [**9-5**] with presumed respiratory distress. Pt
admitted to the ICU and a CVL was placed. At the time of
admission, Pt had stabilized and O2 sat at 100% on a
non-rebreather. Pt was diuresed and cards consulted for CHF med
optimization. HCTZ D/C'd and pt continued lasix, hydralazine,
lopressor, clonidine and imdur. In additon pt with low Hct, pt
cont on epogen and transfused 1U PRBC. A CXR showed a possible
LLL pneumonia, sputum sent and pt started on Zosyn prophylaxis.
Pt improved and pt transferred to the floor. Sputum Cx grew
pseudomanas sensitive to meropenem. In addition, team was
contact[**Name (NI) **] by [**Hospital **] rehab to state that a sputum Cx from [**9-2**]
grew klebsiella also sensitive to meropenem. Zosyn D/C'd and pt
started on meropenem. Repeat CXR revealed resolving pneumonia.
Pt Hct stabilized and continued to improve clinically. Pt D/C'd
to [**Hospital1 **] on [**9-10**] in stable condition

Discharge Medications:
1. Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1)
Tablet PO QD (once a day).
2. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
3. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.) Sig:
One (1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).

4. Metoprolol Tartrate 50 mg Tablet Sig: Three (3) Tablet PO BID
(2 times a day).
5. Prednisone 2.5 mg Tablet Sig: Three (3) Tablet PO QD (once a
day).
6. Epoetin Alfa 4,000 unit/mL Solution Sig: One (1)  Injection
QMOWEFR (Monday -Wednesday-[**Month/Year (2) 2974**]).
7. Beclomethasone Diprop Monohyd 0.042 % Aerosol, Spray Sig: One
(1) Spray Nasal [**Hospital1 **] (2 times a day).
8. Lactulose 10 g/15 mL Syrup Sig: Twenty (20) ML PO QD (once a
day).
9. Metoclopramide HCl 10 mg Tablet Sig: One (1) Tablet PO
QIDACHS (4 times a day (before meals and at bedtime)).
10. Hydralazine HCl 50 mg Tablet Sig: One (1) Tablet PO Q6H
(every 6 hours).
11. Azathioprine 50 mg Tablet Sig: 1.5 Tablets PO QD (once a
day).
12. Insulin Regular Human 100 unit/mL Solution Sig: One (1)
Injection ASDIR (AS DIRECTED).
13. Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO QD
(once a day).
14. Diphenhydramine HCl 25 mg Capsule Sig: One (1) Capsule PO HS
(at bedtime) as needed.
15. Spironolactone 25 mg Tablet Sig: One (1) Tablet PO QD (once
a day).
16. Sertraline HCl 50 mg Tablet Sig: One (1) Tablet PO QD (once
a day).
17. Isosorbide Mononitrate 30 mg Tablet Sustained Release 24HR
Sig: One (1) Tablet Sustained Release 24HR PO QD (once a day).
18. Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID
(4 times a day).
19. Valganciclovir HCl 450 mg Tablet Sig: One (1) Tablet PO QD
(once a day).
20. Clonidine HCl 0.2 mg Tablet Sig: One (1) Tablet PO BID (2
times a day).
21. Furosemide 20 mg Tablet Sig: One (1) Tablet PO QD (once a
day).
22. Sirolimus 1 mg Tablet Sig: Four (4) Tablet PO QD (once a
day).
23. Meropenem 1 g Recon Soln Sig: One (1)  Intravenous  every
twelve (12) hours for 12 days.


Discharge Disposition:
Extended Care

Facility:
[**Hospital3 7**] & Rehab Center - [**Hospital1 8**]

Discharge Diagnosis:
Pneumonia


Discharge Condition:
stable

Discharge Instructions:
Please return for all follow-up appointments
Take all medications as prescribed
Reutrn to the Hospital if any chest pain, shortness of breath,
nausea and vomitting, redness or swelling, significant weight
gain or loss, or fevers

Followup Instructions:
Provider: [**Name10 (NameIs) **] Where: [**Hospital6 29**] SURGICAL SPECIALTIES
Phone:[**Telephone/Fax (1) 274**] Date/Time:[**2145-9-28**] 9:30
Provider: [**Name Initial (NameIs) 1326**]: Please call ([**Telephone/Fax (1) 673**] for an
appointment


                             [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 707**] MD, [**MD Number(3) 709**]

Completed by:[**2145-9-10**]